GO TO SOURCE


NEW DELHI, INDIA, India, July 3, 2002: Joint research conducted by the Scientists of Central Institute of Medicinal and Aromatic Plants, a Central Scientific and Industrial Research (CSIR) laboratory, and Go-Vigyan Anusandhan Kendra, Nagpur, has resulted in the granting of a US patent for a unique pharmaceutical composition, announced Union Minister Murli Manohar Joshi. The research discovered the unique bio-enhancing activity in a specific cow urine distillate, which enhances the anti-microbial effects of antibiotic and anti-fungal agents. Cow urine has been used for its medicinal properties in India since ancient times and has been described as a substance/secretion with innumerable therapeutic values in ”Sushrita Samhita” and ”Ashtanga Sangrah.” This contemporary finding is the synergy of Indian traditional wisdom and modern science. The impact of this novel patent will be on reducing the dosage of drugs to get a given therapeutic effect. It will also reduce the cost of treatment and the side-effects due to toxicity, according to the details of the research paper. Joshi also believed the achievement would give impetus to the traditional researchers of the country. Details of the cow urine patent, entitled Pharmaceutical composition containing cow urine distillate and an antibiotic, #6,410,059, are available at the US Patent Office website: www.patft.uspto.gov/